Authorized generics let brand drug makers sell their own products under a generic label. With patent expirations rising and FDA policy shifting, their role in drug pricing and market competition is changing fast.
Biosimilars and generics both lower drug costs, but they're fundamentally different. Learn how they're made, regulated, and used-so you know what you're really taking.
Drug safety rules vary wildly across countries - the FDA moves fast, the EMA is detailed, and many nations lack basic oversight. Understanding how each system works reveals why the same medicine can be safe in one country and risky in another.